Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Blueprint Medicines Corporation

Biotech Buyers Beware: 3 Stocks to Avoid

The biotech industry is flourishing due to groundbreaking developments in cell and gene therapies and the rapid adoption of new technologies. However, not all biotech stocks are positioned to capitalize on the industry tailwinds. Thus, investors must beware of fundamentally weak stocks: Alpine Immune (ALPN), Kura Oncology (KURA), and Blueprint…

StockNews.com · May 2, 2024

Chart of the Day: Does Blueprint Medicines Have a Blueprint for Success?

Chart of the Day: Does Blueprint Medicines Have a Blueprint for Success?

The Chart of the Day belongs to the cancer biomedical company Blueprint Medicines (BPMC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...

Barchart · Dec 13, 2023

Blueprint Medicines, Proteovant Collaboration For Protein Degrader Therapies

Blueprint Medicines, Proteovant Collaboration For Protein Degrader Therapies

Blueprint Medicines Corporation (NASDAQ: BPMC) and Proteovant Therapeutics have entered a

Benzinga · Feb 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

1

Coverage From

Organisations

Blueprint Medicines

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play